Employer record no. 10616
Bioverativ Therapeutics, Inc.
US DOL LCA disclosure data, FY2020 to FY2026
Total LCA filings
38
Certified
30
Denied
0
FY2025 filings
2
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#828 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 14 | 14 | 0 | $92,197 | $90,286 |
| FY2021 | 7 | 4 | 0 | $112,713 | $103,839 |
| FY2022 | 4 | 1 | 0 | $72,820 | $71,402 |
| FY2023 | 7 | 5 | 0 | $115,018 | $110,246 |
| FY2025 | 2 | 2 | 0 | $102,721 | $102,721 |
| FY2026 * | 4 | 4 | 0 | $132,153 | $132,153 |
What they file for
- senior associate scientist$71,6834
- scientist$96,1243
- senior associate scientist, rare blood disorders$93,1503
- associate director regulatory cmc$159,7442
- associate scientist$82,9302
- global study manager$132,4542
- global supply network planner & analytics$63,0002
- it lead$128,7172
Where
- waltham, ma28
- cambridge, ma10
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Bioverativ Therapeutics, Inc. and any other employer they watch.
Certification rate 78.9%How these numbers are computed